Heterogeneity in randomized controlled trials of long chain (fish) omega-3 fatty acids in restenosis, secondary prevention and ventricular arrhythmias.

@article{Jenkins2008HeterogeneityIR,
  title={Heterogeneity in randomized controlled trials of long chain (fish) omega-3 fatty acids in restenosis, secondary prevention and ventricular arrhythmias.},
  author={David J A Jenkins and Andrea R. Josse and P. Dorian and Michael L Burr and Roxanne LaBelle Trangmar and Cyril W. C. Kendall and Stephen C. Cunnane},
  journal={Journal of the American College of Nutrition},
  year={2008},
  volume={27 3},
  pages={367-78}
}
Randomized controlled trials of marine omega-3 fatty acid supplementation in relation to coronary heart disease (CHD) have inconsistent outcomes, yet public health messages are uniformly positive. Originally, fish were seen as a low saturated fat protein source, and later as a valuable source of omega-3 fatty acids. Early trials indicated that increased fish oil consumption prevented restenosis after coronary angioplasty. Later trials demonstrated that fish oils prolonged life post myocardial… CONTINUE READING
Highly Cited
This paper has 29 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

Are n-3 fatty acids still cardioprotective?

Current opinion in clinical nutrition and metabolic care • 2013

0 Omega-3 fatty acid : Living longer happier from complexities

Girish P. Laddha, Goje Vidya Sagar, Sunil R. Bavaskar, Nilesh bhole
2012

Similar Papers

Loading similar papers…